Targeted Strategies for Today's Evolving Markets

MissionIR Blog

Monthly Archives: June 2023

MissionIRNewsBreaks — Mullen Automotive Inc. (NASDAQ: MULN) Corrects Shareholder Letter to Reflect $0.38 Per Share

Mullen Automotive (NASDAQ: MULN), an emerging electric vehicle (“EV”) manufacturer, has released a letter to its shareholders designed to address the decrease in the company’s share price. The letter noted that earlier this week, the company’s common stock closed at … Continue reading

Posted in Mullen Automotive Inc. MULN | Leave a comment

MissionIRNewsBreaks – CISO Global Inc. (NASDAQ: CISO) Featured in Equity Research Report

CISO Global (NASDAQ: CISO), an industry leading cybersecurity and compliance provider, was featured in a recent equity research report published by Cantor Fitzgerald. The report, titled “Consistent 1Q23 Execution Adjusting for Non-Cash Related Charges/Noise,” adjusts Cantor’s 12-month price target to … Continue reading

Posted in CISO Global Inc. CISO | Leave a comment

MissionIRNewsBreaks – Knightscope, Inc. (NASDAQ: KSCP) K5 ‘Patrol Bot’ to Boost Security Operations at Traverse Point

Knightscope (NASDAQ: KSCP), a leading developer of autonomous security robots and blue light emergency communication systems, announced that Traverse Point Condominiums in Henderson, Nevada, signed a contract for its K5 Autonomous Security Robot (“ASR”) subscription service. The announcement reads, “Traverse … Continue reading

Posted in Knightscope Inc. KSCP | Leave a comment

MissionIRNewsBreaks — Mullen Automotive Inc. (NASDAQ: MULN) Releases Shareholder Letter Featuring Status Update

Mullen Automotive (NASDAQ: MULN), an emerging electric vehicle (“EV”) manufacturer, has issued a shareholder letter providing a business update and responding to questions regarding the company’s share price, which has declined significantly since March 31, 2023; the company currently trades … Continue reading

Posted in Mullen Automotive Inc. MULN | Leave a comment

MissionIRNewsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Announces Participation in Upcoming Maxim Group Virtual Healthcare Conference

CNS Pharmaceuticals (NASDAQ: CNSP), a biopharmaceutical company specializing in the development of novel treatments for primary and metastatic cancers in the brain and central nervous system, will be featured in an upcoming webcast fireside chat. The company announced that CEO … Continue reading

Posted in CNS Pharmaceuticals Inc. CNSP | Leave a comment

D-Wave Quantum Inc. (NYSE: QBTS) and Interpublic Group (NYSE: IPG) Announce Partnership to Use Quantum Computing Applications for Innovation in Marketing Investments and Strategies

D-Wave Quantum (NYSE: QBTS), a leader in quantum computing systems, software, and services focused on delivering customer value via practical quantum computing solutions, recently announced a partnership with one of the world’s leading global advertising and marketing services companies, Interpublic … Continue reading

Posted in D-Wave Quantum Inc. QBTS | Leave a comment

Lexaria Bioscience Corp.’s (NASDAQ: LEXX) May Announcements Show Resolve to Continue Supporting R&D ‘Lifeblood’

Lexaria Bioscience (NASDAQ: LEXX), a global innovator in drug delivery platforms, held its 2023 Annual Meeting on the 9th of May, with shareholders voting on several agenda items, including the election of directors, appointment of auditors, approval of the stock … Continue reading

Posted in Lexaria Bioscience Corp. LEXX | Leave a comment

MissionIRNewsBreaks – Knightscope, Inc. (NASDAQ: KSCP) to Deploy Robots to Join Downtown LA Security Team

Knightscope (NASDAQ: KSCP), a leading developer of autonomous security robots and blue light emergency communication systems, has secured a new contract for one K5 and two K1 Autonomous Security Robots (“ASRs”) from a 50-year real estate developer. The announcement reads, … Continue reading

Posted in Knightscope Inc. KSCP | Leave a comment

Genprex Inc. (NASDAQ: GNPX) Announces Positive Data From Phase 1 Clinical Trial Evaluating REQORSA(R) Immunogene Therapy for Late-Stage Non-Small Cell Lung Cancer

Genprex (NASDAQ: GNPX), a clinical-stage gene therapy company focused on developing life-changing therapies for patients with cancer and diabetes, recently announced that positive data from the Phase 1 portion of its Acclaim-1 clinical trial evaluating REQORSA(R) Immunogene Therapy in combination … Continue reading

Posted in Genprex Inc. GNPX | Leave a comment

Electronic Servitor Publication Network Inc. (XESP) Transforms B2B Companies with “Growth as a Service”

The digital landscape has transformed and evolved over the past few years – going from a focus primarily on SEO, to social media, content, and video marketing campaigns. Now, there are thousands of tactics being thrown on the drawing table … Continue reading

Posted in Electronic Servitor Publication Network Inc. XESP | Leave a comment